Neurocrine Biosciences | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Cytokinetics USD 1.6M 15.33M 2025-03
Dynavax Technologies USD 65M 7.03M 2025-03
Exelixis USD 555.4M 11.35M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Halozyme Therapeutics USD 265M 33.01M 2025-03
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
Prothena USD 2.12M 1.15M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Repligen USD 169M 1000K 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Ultragenyx Pharmaceutical USD 139.29M 25.59M 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Neurocrine Biosciences Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.